Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP254873.RAMHP-l0xso_d14sBeIWn5lId_E17xg5WCU39XtIgrOyM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP254873.RAMHP-l0xso_d14sBeIWn5lId_E17xg5WCU39XtIgrOyM130_assertion type Assertion NP254873.RAMHP-l0xso_d14sBeIWn5lId_E17xg5WCU39XtIgrOyM130_head.
- NP254873.RAMHP-l0xso_d14sBeIWn5lId_E17xg5WCU39XtIgrOyM130_assertion description "[To determine if clinically important drug efflux transporter expression is altered in pregnancies complicated by gestational diabetes mellitus (GDM-I) or type 1 diabetes mellitus (T1DM-I), we compared the expression of multidrug resistance protein 1 (MDR1), multidrug resistance-associated protein 2 (MRP2) and the breast cancer resistance protein (BCRP) via western blotting and quantitative real-time polymerase chain reaction in samples obtained from insulin-managed diabetic pregnancies to healthy term-matched controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254873.RAMHP-l0xso_d14sBeIWn5lId_E17xg5WCU39XtIgrOyM130_provenance.
- NP254873.RAMHP-l0xso_d14sBeIWn5lId_E17xg5WCU39XtIgrOyM130_assertion evidence source_evidence_literature NP254873.RAMHP-l0xso_d14sBeIWn5lId_E17xg5WCU39XtIgrOyM130_provenance.
- NP254873.RAMHP-l0xso_d14sBeIWn5lId_E17xg5WCU39XtIgrOyM130_assertion SIO_000772 22558111 NP254873.RAMHP-l0xso_d14sBeIWn5lId_E17xg5WCU39XtIgrOyM130_provenance.
- NP254873.RAMHP-l0xso_d14sBeIWn5lId_E17xg5WCU39XtIgrOyM130_assertion wasDerivedFrom befree-20140225 NP254873.RAMHP-l0xso_d14sBeIWn5lId_E17xg5WCU39XtIgrOyM130_provenance.
- NP254873.RAMHP-l0xso_d14sBeIWn5lId_E17xg5WCU39XtIgrOyM130_assertion wasGeneratedBy ECO_0000203 NP254873.RAMHP-l0xso_d14sBeIWn5lId_E17xg5WCU39XtIgrOyM130_provenance.